#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Neuromyelitis optica spectrum disorder Dermatitis Malignant peritoneal neoplasm Mucopolysaccharidosis III Medullary thyroid cancer Primary amyloidosis Barth syndrome Progressive multifocal leukoencephalopathy Rhabdoid tumour Waldenstrom's macroglobulinaemia refractory Endometrial adenocarcinoma Activated PI3 kinase delta syndrome Craniocerebral injury Ventricular fibrillation More trials…

    Learn about Rare Diseases

    Anaplastic thyroid cancer – Treatment Breast angiosarcoma metastatic – Trials in Disease Chondrosarcoma metastatic – Life with Disease Hepatic angiosarcoma – Treatment Fragile X syndrome – Life with Disease Breast angiosarcoma Paraneoplastic neurological syndrome – Basic Information Breast angiosarcoma – Life with Disease Waldenstrom’s macroglobulinaemia recurrent – Diagnostics Lymphangiosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Florquinitau (18F) Canakinumab Filgrastim Enzalutamide Ace Inhibitors, Plain Rtx001 TROFOLASTAT Enlicitide Chloride Calcium Chloride Dihydrate Thiamine Nitrate Vortioxetine Hydrobromide Potassium Chloride Octreotide Hydrochloride SOFTISAN 378 Ethanol, Anhydrous Desvenlafaxine Benzoate Ergocalciferol Bp Sodium Valproate Acetazolamide Ivabradine Hydrochloride More therapies…

    Learn about Your Condition

    Fracture infection Scoliosis Propionic acidaemia Non-Hodgkin's lymphoma Polyneuropathy Infection Carotid arteriosclerosis Pruritus Joint stabilisation Lung disorder Pharyngeal cancer stage II Left ventricular dysfunction Limb reduction defect Chronic sinusitis Coagulopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hospital Universitari General De Catalunya

Hospital Universitari General De Catalunya

Carrer Pedro I Pons 1, Sant Cugat Del Valles, 08195, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study of VHB937 to evaluate its effects on cognition and function in people with early Alzheimer’s Disease over 72 weeks

    Recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • VHB937
    Czechia France Germany Italy The Netherlands Poland +2

  • Study of Faricimab Treatment Given Every 24 Weeks in Patients with Age-Related Macular Degeneration

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Faricimab
    France Germany Italy Spain

  • Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Anastrozole
    • Elacestrant
    • Exemestane
    Austria Belgium Czechia Denmark Finland France +9

  • Study on Long-Term Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a Port Delivery System

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Ranibizumab
    Austria Belgium France Germany Italy Spain

  • Study on Long-term Safety of JNJ-81201887 for Patients with Geographic Atrophy Due to Age-related Macular Degeneration

    Recruiting

    2 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Adeno-Associated Virus Serotype 2 Encoding Soluble Cd59
    • Triamcinolone Acetonide
    • Prednisone
    Belgium Czechia Denmark Germany Hungary Italy +5

  • Study on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy

    Recruiting

    3 1
    Investigated Diseases:
    • HER2 positive breast cancer
    • Breast cancer
    Investigated Drugs:
    • L-Isoleucyl-L-Isoleucyl-L-Seryl-L-Alanyl-L-Valyl-L-Valyl-Glycyl-L-Isoleucyl-L-Leucine
    • Sargramostim
    Austria Belgium France Germany Ireland Italy +4

  • Study on the Effects of Prasinezumab in Patients with Early Parkinson’s Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Prasinezumab
    Austria France Germany Spain

  • Study on the Effectiveness of Vaginal Micronized Progesterone for Infertility in Patients Undergoing Assisted Conception with Frozen Embryo Transfer (AC-FET)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility
    Investigated Drugs:
    • Progesterone
    • Estradiol Hemihydrate
    • Progesterone, Micronised
    Spain

  • Study of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to biliary tract
    • Metastatic glioma
    • Metastases to central nervous system
    Investigated Drugs:
    • 6-Fluoro-5-[4-[(5-Fluoro-2-Methyl-3-Oxo-4H-Quinoxalin-6-Yl)Methyl]Piperazin-1-Yl]-N-Methylpyridine-2-Carboxamide
    • [11C]Az14193391
    • Temozolomide
    Spain Sweden

  • Study on the Safety and Effects of ACI-7104.056 in Patients with Early Parkinson’s Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Ioflupane (123I)
    • Pd01B
    Germany Spain
Previous Page
1 2 3 4 … 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!